emodin has been researched along with 3,8-dibromo-7-hydroxy-4-methylchromen-2-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H | 1 |
| Zhang, N; Zhong, R | 1 |
1 review(s) available for emodin and 3,8-dibromo-7-hydroxy-4-methylchromen-2-one
| Article | Year |
|---|---|
Small molecule modulators targeting protein kinase CK1 and CK2.
Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries | 2019 |
1 other study(ies) available for emodin and 3,8-dibromo-7-hydroxy-4-methylchromen-2-one
| Article | Year |
|---|---|
Docking and 3D-QSAR studies of 7-hydroxycoumarin derivatives as CK2 inhibitors.
Topics: Casein Kinase II; Chromones; Drug Design; Emodin; Humans; Ligands; Models, Molecular; Protein Conformation; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Umbelliferones | 2010 |